Skip to main content
OpenTrials
Completed

NCT Number: NCT06665581

Keratinocyte Skin Cancer Surgery in the Elderly, Aged 80 Years and Over, is Effective and Safe

As a result of a longer life expectancy and a change in UV exposure, physicians will be facing a growing number of elderly patients with keratinocyte cancer (KC) in fair-skinned populations. The purpose of this study is to better characterize KC surgery in patients over 80 years and older with different comorbid conditions and to investigate the incidence of complications associated with KC surgery.

A retrospective monocentric study of patients aged 80 and older, having surgery for KC in University Hospital of Zurich between January 1, 2022, and December 31, 2022, was conducted. Demographics, comorbidities, current medication, treatment type, tumor characteristics, surgical defect size, repair type and complications within 6 months after surgery were analyzed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Complication Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications

Age range

80 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Zurich, Zurich, Canton of Zurich, Switzerland

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 80 and older, having surgery for KC in University Hospital of Zurich between January 1, 2022, and December 31, 2022

Exclusion criteria

  • Presence of a documented rejection.

Treatment and study plan

Primary outcomes

  1. Incidence of complications associated with KC surgery in individuals aged 80 years and older

    Time frame: From January 1, 2022, to December 31, 2022

Sponsors and collaborators

Lead sponsor

Juerg Hafner

Other

Registry information

Official study title

Keratinocyte Skin Cancer Surgery in the Elderly, Aged 80 Years and Over, is Effective and Safe: a Single Institution Retrospective Study Over One Year

Important dates

Study start
2022
Primary completion
2023
Study completion
2024
First posted
Oct 30, 2024
Registry last updated
Oct 30, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.